Weiju Wu

581 citations
19 papers · 468 indexed · h-index 12

Impact in

    • Renal Transplantation Outcomes and Treatments
  • Nephrology top 5%
    • Renal Diseases and Glomerulopathies
    • Acute Kidney Injury Research

Papers in

Weiju Wu

19 papers receiving 461 citations

Peers

Weiju Wu
Comparison fields: 5 of 71
  • Transplantation 52
  • Nephrology 112
  • Immunology 232
  • Endocrinology 21
  • Ophthalmology 33
Replace Ricardo A. Brooimans with:
Ricardo A. Brooimans Netherlands
Mohamed R. Daha Netherlands
Jan A. Bruijn Netherlands
L. A. van Es Netherlands
Jennifer R. Timoshanko Australia
Róbert Szász Hungary
Claudia Wegscheid Germany
Frank Ierino Australia
Hidekazu Yamamoto Japan
Weiju Wu relative to Ricardo A. Brooimans Netherlands Ricardo A. Brooimans's profile →
Citations per field
00.5×10×13.8×
Ricardo A. Brooimans · 1×
Citations per year

Countries citing papers authored by Weiju Wu

Since Specialization
Citations

This map shows the geographic impact of Weiju Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiju Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiju Wu more than expected).

Fields of papers citing papers by Weiju Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiju Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiju Wu. The network helps show where Weiju Wu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Weiju Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Weiju Wu Line = papers co-authored together Weiju Wu links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1 202314
2 20236
3 20214
4 202113
5 201954
6 20187
7 20181
8 20181
9 201734
10 201711
11 201719
12 201745
13 201652
14 20161
15 2016112
16 201523
17 20155
18 201541
19 201325

About Weiju Wu

Weiju Wu is a scholar working on Nephrology, Immunology and Allergy, Urology, Endocrinology and Immunology, having authored 19 papers that have together received 468 indexed citations. Recurring topics across this work include Connexins and lens biology (5 papers), Complement system in diseases (4 papers), Renal Diseases and Glomerulopathies (3 papers), Urinary Tract Infections Management (3 papers), Cell Adhesion Molecules Research (3 papers), Urinary Bladder and Prostate Research (3 papers), Galectins and Cancer Biology (3 papers) and Biomedical Research and Pathophysiology (2 papers). The work is most often cited by research in Transplantation (52 citations), Nephrology (112 citations), Immunology (232 citations), Endocrinology (21 citations) and Ophthalmology (33 citations). Weiju Wu has collaborated with scholars based in United Kingdom, China and Denmark. Frequent co-authors include Wuding Zhou, Steven H. Sacks, Conrad A. Farrar, Qi Peng, Ke Li, Ke Li, Kunyi Wu, Wilhelm Schwaeble, David Tran and Chengfei Liu. Their work appears in journals such as Kidney International, Experimental Eye Research, Frontiers in Immunology, Molecular Immunology and JCI Insight.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026